Literature DB >> 10090896

Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31.

A Blumenfeld1, S A Slaugenhaupt, C B Liebert, V Temper, C Maayan, S Gill, D E Lucente, M Idelson, K MacCormack, M A Monahan, J Mull, M Leyne, M Mendillo, T Schiripo, E Mishori, X Breakefield, F B Axelrod, J F Gusella.   

Abstract

Familial dysautonomia (FD) is an autosomal recessive disorder characterized by developmental arrest in the sensory and autonomic nervous systems and by Ashkenazi Jewish ancestry. We previously had mapped the defective gene (DYS) to an 11-cM segment of chromosome 9q31-33, flanked by D9S53 and D9S105. By using 11 new polymorphic loci, we now have narrowed the location of DYS to <0.5 cM between the markers 43B1GAGT and 157A3. Two markers in this interval, 164D1 and D9S1677, show no recombination with the disease. Haplotype analysis confirmed this candidate region and revealed a major haplotype shared by 435 of 441 FD chromosomes, indicating a striking founder effect. Three other haplotypes, found on the remaining 6 FD chromosomes, might represent independent mutations. The frequency of the major FD haplotype in the Ashkenazim (5 in 324 control chromosomes) was consistent with the estimated DYS carrier frequency of 1 in 32, and none of the four haplotypes associated with FD was observed on 492 non-FD chromosomes from obligatory carriers. It is now possible to provide accurate genetic testing both for families with FD and for carriers, on the basis of close flanking markers and the capacity to identify >98% of FD chromosomes by their haplotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090896      PMCID: PMC1377835          DOI: 10.1086/302339

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  Report on the Fifth International Workshop on Chromosome 9 held at Eynsham, Oxfordshire, UK, September 4-6, 1996.

Authors:  S Povey; J Attwood; B Chadwick; J Frezal; J L Haines; M Knowles; D J Kwiatkowski; O I Olopade; S Slaugenhaupt; N K Spurr; M Smith; K Steel; J A White; M A Pericak-Vance
Journal:  Ann Hum Genet       Date:  1997-05       Impact factor: 1.670

2.  Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.

Authors:  B L Triggs-Raine; A S Feigenbaum; M Natowicz; M A Skomorowski; S M Schuster; J T Clarke; D J Mahuran; E H Kolodny; R A Gravel
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

3.  Incidence of familial dysautonomia in Israel 1977-1981.

Authors:  C Maayan; E Kaplan; S Shachar; O Peleg; S Godfrey
Journal:  Clin Genet       Date:  1987-08       Impact factor: 4.438

4.  Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines.

Authors:  M A Anderson; J F Gusella
Journal:  In Vitro       Date:  1984-11

5.  Familial dysautonomia: a prospective study of survival.

Authors:  F B Axelrod; J J Abularrage
Journal:  J Pediatr       Date:  1982-08       Impact factor: 4.406

6.  DNA polymorphisms for the nerve growth factor receptor gene exclude its role in familial dysautonomia.

Authors:  X O Breakefield; L Ozelius; M A Bothwell; M V Chao; F Axelrod; P L Kramer; K K Kidd; A A Lanahan; D E Johnson; A H Ross
Journal:  Mol Biol Med       Date:  1986-12

7.  Reduced neuronotrophic activity of fibroblasts from individuals with dysautonomia in cultures of newborn mouse sensory ganglion cells.

Authors:  J R Wrathall
Journal:  Brain Res       Date:  1986-01-29       Impact factor: 3.252

8.  Dysautonomia in an infant with secondary hyperammonemia due to propionyl coenzyme A carboxylase deficiency.

Authors:  D J Harris; B I Yang; B Wolf; P J Snodgrass
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

9.  Structural gene for beta-nerve growth factor not defective in familial dysautonomia.

Authors:  X O Breakefield; G Orloff; C Castiglione; L Coussens; F B Axelrod; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

10.  Congenital sensory neuropathies. Diagnostic distinction from familial dysautonomia.

Authors:  F B Axelrod; J Pearson
Journal:  Am J Dis Child       Date:  1984-10
View more
  15 in total

1.  Afferent baroreflex failure in familial dysautonomia.

Authors:  Lucy Norcliffe-Kaufmann; Felicia Axelrod; Horacio Kaufmann
Journal:  Neurology       Date:  2010-11-23       Impact factor: 9.910

2.  Detecting population growth, selection and inherited fertility from haplotypic data in humans.

Authors:  Frédéric Austerlitz; Luba Kalaydjieva; Evelyne Heyer
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

3.  A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases.

Authors:  Montgomery Slatkin
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

4.  Age estimate of the N370S mutation causing Gaucher disease in Ashkenazi Jews and European populations: A reappraisal of haplotype data.

Authors:  R Colombo
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

5.  An electric lobe suppressor for a yeast choline transport mutation belongs to a new family of transporter-like proteins.

Authors:  S O'Regan; E Traiffort; M Ruat; N Cha; D Compaore; F M Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

6.  Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia.

Authors:  S A Slaugenhaupt; A Blumenfeld; S P Gill; M Leyne; J Mull; M P Cuajungco; C B Liebert; B Chadwick; M Idelson; L Reznik; C Robbins; I Makalowska; M Brownstein; D Krappmann; C Scheidereit; C Maayan; F B Axelrod; J F Gusella
Journal:  Am J Hum Genet       Date:  2001-01-22       Impact factor: 11.025

7.  BGP-15 prevents the death of neurons in a mouse model of familial dysautonomia.

Authors:  Sarah B Ohlen; Magdalena L Russell; Michael J Brownstein; Frances Lefcort
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 8.  The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

9.  Riley-Day Syndrome in a Hispanic Infant of Non-Jewish Ashkenazi Descent.

Authors:  Abel Ramírez-Estudillo; Gerardo González-Saldivar; Itzel Espinosa-Soto; Jesús González-Cortez; Alejandro Salcido-Montenegro
Journal:  J Clin Diagn Res       Date:  2017-07-01

10.  Loss of mouse Ikbkap, a subunit of elongator, leads to transcriptional deficits and embryonic lethality that can be rescued by human IKBKAP.

Authors:  Yei-Tsung Chen; Matthew M Hims; Ranjit S Shetty; James Mull; Lijuan Liu; Maire Leyne; Susan A Slaugenhaupt
Journal:  Mol Cell Biol       Date:  2008-11-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.